Annual Net Income
-$5.12 M
+$7.61 M+59.76%
31 December 2023
Summary:
Adial Pharmaceuticals annual net profit is currently -$5.12 million, with the most recent change of +$7.61 million (+59.76%) on 31 December 2023. During the last 3 years, it has risen by +$5.77 million (+52.97%). ADIL annual net income is now -1119.25% below its all-time high of -$420.20 thousand, reached on 31 December 2016.ADIL Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$2.19 M
+$266.50 K+10.84%
30 September 2024
Summary:
Adial Pharmaceuticals quarterly net profit is currently -$2.19 million, with the most recent change of +$266.50 thousand (+10.84%) on 30 September 2024. Over the past year, it has dropped by -$806.80 thousand (-58.25%). ADIL quarterly net income is now -301.49% below its all-time high of $1.09 million, reached on 30 June 2023.ADIL Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$13.05 M
-$806.80 K-6.59%
30 September 2024
Summary:
Adial Pharmaceuticals TTM net profit is currently -$13.05 million, with the most recent change of -$806.80 thousand (-6.59%) on 30 September 2024. Over the past year, it has dropped by -$6.98 million (-114.95%). ADIL TTM net income is now -13533.23% below its all-time high of -$95.70 thousand, reached on 30 June 2016.ADIL TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADIL Net Income Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +59.8% | -58.3% | -115.0% |
3 y3 years | +53.0% | +49.2% | +23.5% |
5 y5 years | +56.0% | -27.7% | -67.2% |
ADIL Net Income High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | at high | +73.6% | -301.5% | +66.2% | -154.7% | +32.8% |
5 y | 5 years | at high | +73.6% | -301.5% | +66.2% | -154.7% | +32.8% |
alltime | all time | -1119.3% | +73.6% | -301.5% | +73.2% | <-9999.0% | +32.8% |
Adial Pharmaceuticals Net Income History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$2.19 M(-10.8%) | -$13.05 M(+6.6%) |
June 2024 | - | -$2.46 M(-62.0%) | -$12.24 M(+40.8%) |
Mar 2024 | - | -$6.48 M(+237.3%) | -$8.69 M(+69.7%) |
Dec 2023 | -$5.12 M(-59.8%) | -$1.92 M(+38.6%) | -$5.12 M(-15.6%) |
Sept 2023 | - | -$1.39 M(-227.3%) | -$6.07 M(-22.1%) |
June 2023 | - | $1.09 M(-137.4%) | -$7.79 M(-38.8%) |
Mar 2023 | - | -$2.91 M(+1.4%) | -$12.73 M(-0.0%) |
Dec 2022 | -$12.73 M(-34.5%) | -$2.87 M(-7.8%) | -$12.73 M(-18.9%) |
Sept 2022 | - | -$3.11 M(-19.2%) | -$15.70 M(-7.1%) |
June 2022 | - | -$3.85 M(+32.3%) | -$16.90 M(-3.4%) |
Mar 2022 | - | -$2.91 M(-50.1%) | -$17.50 M(-9.9%) |
Dec 2021 | -$19.42 M(+78.3%) | -$5.83 M(+35.0%) | -$19.42 M(+13.8%) |
Sept 2021 | - | -$4.32 M(-2.8%) | -$17.06 M(+6.1%) |
June 2021 | - | -$4.44 M(-8.1%) | -$16.08 M(+19.6%) |
Mar 2021 | - | -$4.83 M(+39.3%) | -$13.45 M(+23.5%) |
Dec 2020 | -$10.89 M | -$3.47 M(+4.0%) | -$10.89 M(+14.9%) |
Sept 2020 | - | -$3.34 M(+84.2%) | -$9.48 M(+20.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2020 | - | -$1.81 M(-20.5%) | -$7.86 M(-3.9%) |
Mar 2020 | - | -$2.28 M(+10.6%) | -$8.19 M(-4.7%) |
Dec 2019 | -$8.59 M(-26.1%) | -$2.06 M(+20.0%) | -$8.59 M(+10.1%) |
Sept 2019 | - | -$1.72 M(-19.6%) | -$7.80 M(-45.4%) |
June 2019 | - | -$2.13 M(-20.4%) | -$14.28 M(+2.5%) |
Mar 2019 | - | -$2.68 M(+111.4%) | -$13.94 M(+19.8%) |
Dec 2018 | -$11.63 M(+920.7%) | -$1.27 M(-84.5%) | -$11.63 M(+8.0%) |
Sept 2018 | - | -$8.19 M(+357.0%) | -$10.77 M(+275.4%) |
June 2018 | - | -$1.79 M(+372.9%) | -$2.87 M(+114.0%) |
Mar 2018 | - | -$379.00 K(-6.2%) | -$1.34 M(+17.6%) |
Dec 2017 | -$1.14 M(+171.2%) | -$404.00 K(+38.1%) | -$1.14 M(+37.1%) |
Sept 2017 | - | -$292.60 K(+10.7%) | -$831.00 K(+29.5%) |
June 2017 | - | -$264.30 K(+48.0%) | -$641.80 K(+35.6%) |
Mar 2017 | - | -$178.60 K(+87.0%) | -$473.20 K(+60.6%) |
Dec 2016 | -$420.20 K(-48.6%) | -$95.50 K(-7.6%) | -$294.60 K(+48.0%) |
Sept 2016 | - | -$103.40 K(+8.0%) | -$199.10 K(+108.0%) |
June 2016 | - | -$95.70 K | -$95.70 K |
Dec 2015 | -$818.00 K | - | - |
FAQ
- What is Adial Pharmaceuticals annual net profit?
- What is the all time high annual net income for Adial Pharmaceuticals?
- What is Adial Pharmaceuticals annual net income year-on-year change?
- What is Adial Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Adial Pharmaceuticals?
- What is Adial Pharmaceuticals quarterly net income year-on-year change?
- What is Adial Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Adial Pharmaceuticals?
- What is Adial Pharmaceuticals TTM net income year-on-year change?
What is Adial Pharmaceuticals annual net profit?
The current annual net income of ADIL is -$5.12 M
What is the all time high annual net income for Adial Pharmaceuticals?
Adial Pharmaceuticals all-time high annual net profit is -$420.20 K
What is Adial Pharmaceuticals annual net income year-on-year change?
Over the past year, ADIL annual net profit has changed by +$7.61 M (+59.76%)
What is Adial Pharmaceuticals quarterly net profit?
The current quarterly net income of ADIL is -$2.19 M
What is the all time high quarterly net income for Adial Pharmaceuticals?
Adial Pharmaceuticals all-time high quarterly net profit is $1.09 M
What is Adial Pharmaceuticals quarterly net income year-on-year change?
Over the past year, ADIL quarterly net profit has changed by -$806.80 K (-58.25%)
What is Adial Pharmaceuticals TTM net profit?
The current TTM net income of ADIL is -$13.05 M
What is the all time high TTM net income for Adial Pharmaceuticals?
Adial Pharmaceuticals all-time high TTM net profit is -$95.70 K
What is Adial Pharmaceuticals TTM net income year-on-year change?
Over the past year, ADIL TTM net profit has changed by -$6.98 M (-114.95%)